Centiva Capital, LP Bio N Tech Se Put Options Transaction History

Centiva Capital, LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $1.23 Million - $1.76 Million	-9,600 Reduced 31.07%	21,300 $2.87 Million
Q2 2022 Aug 17, 2022	BUY	$123.25 - $186.24 $1.53 Million - $2.31 Million	12,400 Added 67.03%	30,900 $4.61 Million
Q1 2022 May 16, 2022	BUY	$126.25 - $231.85 $694,375 - $1.28 Million	5,500 Added 42.31%	18,500 $3.16 Million
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $2.6 Million - $4.34 Million	11,980 Added 1174.51%	13,000 $3.35 Million
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $210,048 - $456,174	1,020 New	1,020 $278,000

357

38.4M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $25.8B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.